Introduction to PT-141 3mg Kits (30mg Total)

PT-141 (Bremelanotide) 3mg is a synthetic cyclic heptapeptide analog of endogenous alpha-melanocyte-stimulating hormone ($\alpha$-MSH). Structurally derived as a purified metabolite of Melanotan II, PT-141 lacks the C-terminal amide group, a modification that alters its affinity profile and minimizes local melanogenesis signaling. At USA PEPTIDE SCIENCES, we present this compound in a high-resolution laboratory kit consisting of 10 individual 3mg vials (30mg total volume). Each vial is independently vacuum-sealed and lyophilized to ensure baseline continuity, precise multi-dose calculations, and long-term chemical preservation across intensive multi-subject protocols.

Research Overview: Central Melanocortin Receptor Agonism

The primary investigative profile of PT-141 centers on its role as a non-selective agonist at the central melanocortin receptors, displaying prominent binding affinity for the MC3R and MC4R sub-types located within the central nervous system. Unlike peripheral small-molecule compounds that act directly on local vascular smooth muscle tissue, PT-141 triggers downstream physiological responses via neurochemical signaling networks in the hypothalamus.

Key areas of active scientific investigation utilizing the 3mg x 10 vial kit include:

• Neurogenic Autonomic Pathways: Mapping the central nervous system cascades that modulate efferent autonomic signaling pathways from the medial preoptic area (mPOA) of the brain.

• Melanocortin Receptor Specificity: Investigating the differential activation kinetics between MC3R and MC4R and their combined role in regulating autonomic and behavioral reflex responses.

• Microvascular and Blood Pressure Kinetics: Monitoring alterations in local blood flow, vascular resistance, and systemic blood pressure markers associated with central melanocortin saturation.

• Satiety and Energy Expenditure Crosstalk: Evaluating how central MC4R activation by Bremelanotide intersects with metabolic pathways governing appetite suppression and baseline cellular energy regulation.

Quality Standards & Analytical Testing

At USA PEPTIDE SCIENCES, laboratory accuracy and structural consistency are our absolute prerequisites. Each lot within the PT-141 30mg Kit is manufactured under stringent quality control protocols to eliminate experimental variables. We employ High-Performance Liquid Chromatography (HPLC) to verify an absolute chemical purity profile of 99% or greater across all 10 vials. Additionally, Mass Spectrometry (MS) is carried out to validate the exact amino acid sequence alignment and ensure the perfect configuration of the cyclic disulfide bond. A batch-specific Certificate of Analysis (COA) is provided to back the structural data of every kit.

Storage and Handling Requirements

To maintain the structural stability of the PT-141 3mg lyophilized matrix, the unconstituted vials must be kept frozen at -20°C for extended storage. Prior to conducting laboratory assays, reconstitution should be carried out using an appropriate sterile or bacteriostatic diluent. Once transitioned into a liquid state, the peptide is highly sensitive to thermal degradation and structural shearing. Reconstituted vials must be stored under constant refrigeration at 2°C to 8°C. To prevent mechanical damage to the delicate cyclic chain, never shake the vial; dissolve the lyophilized cake using a slow, gentle swirling motion.

Research Use Disclaimer

The compounds distributed by USA PEPTIDE SCIENCES, including the PT-141 3mg x 10 Vials (30mg Kit), are intended strictly for laboratory research purposes only. These products are not for human or veterinary administration, consumption, clinical diagnostics, or therapeutic drug use. All experimental protocols, reconstitution, and analytical evaluations must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.